Actively Recruiting

Age: 2Years - 120Years
All Genders
NCT00001244

Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI)

Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-05-07

500

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to understand the causes and progression of Common Variable Immunodeficiency (CVID) and related inborn errors of immunity (IEI). These are conditions where the immune system does not function properly, leading to frequent infections and other complications such as gastrointestinal inflammation, lung and liver disease, autoimmune conditions, and an increased risk of certain cancers. By studying patients with CVI and related immune disorders, we hope to develop better ways to diagnose, treat, and prevent complications associated with these conditions. Patients diagnosed with CVID or related immune disorders must be referred by their physician and medical records reviewed by the study team to confirm eligibility to participate in this study. Once enrolled, participants will undergo various tests, including blood draws, physical exams, and imaging studies like CT scans to track changes over time. We may collect samples such as blood, urine, stool, or saliva for research purposes. If a surgical procedure or biopsy is performed because it is medically necessary, we may collect an additional sample for research testing. Family members of patients may be asked to provide blood samples for comparison. Some tests may be done remotely if participants or family members cannot travel to the study site. Who Can Participate * Patients diagnosed with CVI or related IEI, such as X-linked agammaglobulinemia, Blau Syndrome or Yao Syndrome. * Participants must be at least 2 years old. * Family members of patients may include parents, siblings, grandparents, children, aunts, uncles, and cousins. * Pregnant women already enrolled in the study will continue to participate, but new pregnant participants will not be enrolled. Potential Risks and Benefits * Risks: Blood draws may cause discomfort, bruising, or infection. Apheresis may cause dizziness, nausea, or muscle cramps; this procedure is to collect specific cells in the blood and is infrequently done on this protocol. Extra biopsies during clinically indicated procedures may increase the risk of complications; they will only be collected after the medically necessary biopsies are taken and if it is safe to collect any extra biopsies. * Benefits: Participants may not receive direct medical benefits, but the study will contribute to a better understanding of CVID and related conditions, potentially leading to improved treatments.

CONDITIONS

Official Title

Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI)

Who Can Participate

Age: 2Years - 120Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Must have a confirmed diagnosis of common variable immune deficiency or related B-cell immunodeficiencies including selective IgA deficiency, selective IgG isotype deficiency, agammaglobulinemia, hypogammaglobulinemia linked to Epstein-Barr virus infection, Blau Syndrome, or Yao Syndrome
  • Must be 2 years old or older
  • Patients with repeated infections suspected of having an inborn error of immunity
  • Must be referred by their primary medical care provider
  • Unaffected first- or second-degree family members may be asked to provide blood or buccal specimens for research
  • Lactating patients may participate with tests and procedures considered minimal risk to the child
  • Pregnant women enrolled before pregnancy may continue with minimal risk tests and procedures
  • All patients must agree to store research samples for future studies
  • NIH staff and family members of study team members may be enrolled if they meet criteria
Not Eligible

You will not qualify if you...

  • Presence of other medical illnesses that prevent undergoing routine diagnostic or immunologic testing
  • Conditions or treatments like HIV, cytotoxic chemotherapy, or malignancy that could interfere with study evaluation
  • Pregnancy at the time of enrollment
  • Adults unable to provide informed consent for themselves due to decision-making impairment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Institutes of Health Clinical Center

Bethesda, Maryland, United States, 20892

Actively Recruiting

Loading map...

Research Team

K

Kimberly L Montgomery-Recht, R.N.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here